|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1850 AUD | +2.78% |
|
0.00% | -60.64% |
| Feb. 26 | SciDev Limited, H1 2026 Earnings Call, Feb 26, 2026 | |
| Feb. 25 | SciDev Limited Revises Earnings Guidance for the Year 2026 | CI |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.64 | -0.05 | 0.52 | 4.28 | 2.51 | |||||
Return on Total Capital | 2.5 | -0.07 | 0.7 | 5.71 | 3.39 | |||||
Return On Equity % | 14.09 | -1.53 | -0.7 | 4.43 | -1.75 | |||||
Return on Common Equity | 14.09 | -1.53 | -0.7 | 4.43 | -1.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 22.41 | 28.16 | 25.66 | 30.08 | 32.26 | |||||
SG&A Margin | 19.2 | 20.48 | 16.72 | 18.75 | 21.7 | |||||
EBITDA Margin % | 3.35 | 2 | 2.59 | 7 | 5.71 | |||||
EBITA Margin % | 2.64 | 0.93 | 1.45 | 4.87 | 3.36 | |||||
EBIT Margin % | 2.57 | -0.09 | 0.64 | 4.37 | 2.86 | |||||
Income From Continuing Operations Margin % | 8.12 | -1.11 | -0.38 | 1.99 | -0.85 | |||||
Net Income Margin % | 8.12 | -1.11 | -0.38 | 1.99 | -0.85 | |||||
Net Avail. For Common Margin % | 8.12 | -1.11 | -0.38 | 1.99 | -0.85 | |||||
Normalized Net Income Margin | 1.51 | -1.28 | -0.17 | 2.35 | 0.88 | |||||
Levered Free Cash Flow Margin | 1.89 | -7.39 | 1.2 | 2.75 | 0.28 | |||||
Unlevered Free Cash Flow Margin | 2.11 | -6.59 | 1.45 | 3.12 | 0.66 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.02 | 0.87 | 1.3 | 1.57 | 1.41 | |||||
Fixed Assets Turnover | 11.22 | 7.85 | 8.77 | 9.01 | 9.08 | |||||
Receivables Turnover (Average Receivables) | 9.37 | 6.51 | 9.82 | 10.84 | 7.43 | |||||
Inventory Turnover (Average Inventory) | 7.68 | 7.17 | 9.36 | 10.57 | 9.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.19 | 1.72 | 1.41 | 1.49 | 1.56 | |||||
Quick Ratio | 0.93 | 1.31 | 0.96 | 1.08 | 1.17 | |||||
Operating Cash Flow to Current Liabilities | -0.08 | -0.07 | 0.28 | 0.32 | 0.13 | |||||
Days Sales Outstanding (Average Receivables) | 38.94 | 56.03 | 37.17 | 33.75 | 49.14 | |||||
Days Outstanding Inventory (Average Inventory) | 47.55 | 50.9 | 39.01 | 34.64 | 38.9 | |||||
Average Days Payable Outstanding | 88.11 | 77.23 | 56.23 | 62.24 | 85.85 | |||||
Cash Conversion Cycle (Average Days) | -1.61 | 29.7 | 19.95 | 6.16 | 2.19 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 16.23 | 5.93 | 7.24 | 5.58 | 12.51 | |||||
Total Debt / Total Capital | 13.96 | 5.6 | 6.75 | 5.29 | 11.12 | |||||
LT Debt/Equity | 8.43 | 0.7 | 5.03 | 3.26 | 6.85 | |||||
Long-Term Debt / Total Capital | 7.25 | 0.66 | 4.69 | 3.09 | 6.08 | |||||
Total Liabilities / Total Assets | 43.7 | 31.37 | 28.72 | 30.24 | 33.47 | |||||
EBIT / Interest Expense | 7.4 | -0.07 | 1.64 | 7.34 | 4.72 | |||||
EBITDA / Interest Expense | 13.71 | 2.87 | 11.55 | 13.64 | 11.37 | |||||
(EBITDA - Capex) / Interest Expense | 10.9 | -0.5 | -0.07 | 10.56 | 8.05 | |||||
Total Debt / EBITDA | 2.54 | 1.43 | 0.85 | 0.32 | 0.88 | |||||
Net Debt / EBITDA | -0.93 | -5.5 | -1.04 | -0.75 | -0.48 | |||||
Total Debt / (EBITDA - Capex) | 3.19 | -8.22 | -133.81 | 0.41 | 1.24 | |||||
Net Debt / (EBITDA - Capex) | -1.17 | 31.73 | 163.58 | -0.96 | -0.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 135.45 | 30.74 | 61.59 | 21.55 | -5.25 | |||||
Gross Profit, 1 Yr. Growth % | 216.67 | 83.12 | 47.25 | 42.34 | 1.6 | |||||
EBITDA, 1 Yr. Growth % | -179.23 | 5.2 | 109.25 | 225.3 | -22.73 | |||||
EBITA, 1 Yr. Growth % | -154.41 | -31.61 | 151.45 | 302.12 | -34.68 | |||||
EBIT, 1 Yr. Growth % | -152.52 | -107.16 | -1.21K | 692.86 | -37.94 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -494.52 | -117.84 | -44.97 | -741.59 | -140.37 | |||||
Net Income, 1 Yr. Growth % | -494.52 | -117.84 | -44.97 | -741.59 | -140.37 | |||||
Normalized Net Income, 1 Yr. Growth % | -146.97 | -246.66 | -78.53 | -1.95K | -64.51 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -423.17 | -115.7 | -48.57 | -736.44 | -145.45 | |||||
Accounts Receivable, 1 Yr. Growth % | 229.79 | 45.1 | -18.91 | 56.22 | 26.59 | |||||
Inventory, 1 Yr. Growth % | -21.07 | 93.67 | -5.66 | 8.64 | -1.49 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 433.41 | 21.74 | 63.75 | -9.53 | -2.08 | |||||
Total Assets, 1 Yr. Growth % | 106.64 | 26.72 | -5.32 | 6.89 | 4.46 | |||||
Tangible Book Value, 1 Yr. Growth % | 24.6 | 287.3 | -2.44 | 12.44 | 0.48 | |||||
Common Equity, 1 Yr. Growth % | 81.6 | 54.47 | -1.66 | 4.61 | -0.37 | |||||
Cash From Operations, 1 Yr. Growth % | 642.05 | -0.84 | -468.61 | 34.61 | -55.77 | |||||
Capital Expenditures, 1 Yr. Growth % | -44.94 | 475.36 | 72.67 | -51.33 | 3.95 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 259.63 | -814.24 | -128.4 | 112.99 | -90.28 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 264.5 | -649.05 | -135.53 | 109 | -79.93 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 281.55 | 75.45 | 45.35 | 40.17 | 7.32 | |||||
Gross Profit, 2 Yr. CAGR % | 222.65 | 128.11 | 64.21 | 44.87 | 20.26 | |||||
EBITDA, 2 Yr. CAGR % | -7.87 | -21.29 | 48.37 | 162.19 | 58.54 | |||||
EBITA, 2 Yr. CAGR % | -21.75 | -49.93 | 31.13 | 220.78 | 62.07 | |||||
EBIT, 2 Yr. CAGR % | -23.97 | -84.19 | -10.7 | 858.06 | 121.82 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 30.34 | -16.11 | -68.67 | 87.91 | 60.93 | |||||
Net Income, 2 Yr. CAGR % | 30.34 | -16.11 | -68.67 | 87.91 | 60.93 | |||||
Normalized Net Income, 2 Yr. CAGR % | -28.09 | -27.66 | -43.88 | 89.61 | 156.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -8.95 | -28.78 | -71.59 | 80.92 | 66.67 | |||||
Accounts Receivable, 2 Yr. CAGR % | 198.93 | 118.77 | 8.47 | 10.26 | 40.63 | |||||
Inventory, 2 Yr. CAGR % | 278.8 | 23.65 | 35.17 | 1.24 | 3.45 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 358.66 | 154.83 | 41.19 | 21.72 | -5.88 | |||||
Total Assets, 2 Yr. CAGR % | 208.45 | 61.82 | 9.54 | 0.6 | 5.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 47.23 | 95.52 | 94.38 | 4.74 | 6.29 | |||||
Common Equity, 2 Yr. CAGR % | 159.38 | 67.49 | 23.25 | 1.42 | 2.09 | |||||
Cash From Operations, 2 Yr. CAGR % | -7.77 | 171.28 | 91.19 | 122.75 | -22.84 | |||||
Capital Expenditures, 2 Yr. CAGR % | 35.66 | 77.89 | 215.19 | -8.32 | -28.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 4.59 | 328.53 | 37.12 | -11.26 | -54.51 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 10.74 | 286.01 | 39.68 | -3.63 | -35.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 168.34 | 167 | 70.7 | 36.96 | 23.02 | |||||
Gross Profit, 3 Yr. CAGR % | 116.03 | 157.66 | 97.14 | 56.64 | 28.71 | |||||
EBITDA, 3 Yr. CAGR % | 21.52 | -12.77 | 9.04 | 93.38 | 74.48 | |||||
EBITA, 3 Yr. CAGR % | 6.81 | -34.41 | -14.25 | 91.63 | 88.72 | |||||
EBIT, 3 Yr. CAGR % | 3.42 | -69.81 | -34.7 | 87.33 | 284.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 51.05 | -32.83 | -27.11 | -14.28 | 12.54 | |||||
Net Income, 3 Yr. CAGR % | 51.05 | -32.83 | -27.11 | -14.28 | 12.54 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.95 | -16.8 | -51.75 | 74.05 | 8.47 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.35 | -49.33 | -36.1 | -19.91 | 12.62 | |||||
Accounts Receivable, 3 Yr. CAGR % | 147.83 | 134.94 | 57.15 | 20.83 | 15.46 | |||||
Inventory, 3 Yr. CAGR % | 152.29 | 202.9 | 12.98 | 25.68 | 0.32 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 190.3 | 194.77 | 119.9 | 21.72 | 13.2 | |||||
Total Assets, 3 Yr. CAGR % | 130.85 | 129.3 | 35.35 | 8.65 | 1.87 | |||||
Tangible Book Value, 3 Yr. CAGR % | 40.75 | 88.06 | 55.08 | 61.96 | 3.3 | |||||
Common Equity, 3 Yr. CAGR % | 100.02 | 118.23 | 40.25 | 16.69 | 0.82 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.85 | -5.51 | 200.47 | 70.08 | 29.95 | |||||
Capital Expenditures, 3 Yr. CAGR % | 62.25 | 119.5 | 76.13 | 69.1 | -4.4 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.3 | 77.44 | 69.08 | 73.39 | -57.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -0.63 | 71.14 | 74.29 | 72.12 | -42.88 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 97.28 | 95.94 | 109.98 | 106.33 | 41.79 | |||||
Gross Profit, 5 Yr. CAGR % | 70.33 | 76.14 | 89.43 | 104.65 | 61.82 | |||||
EBITDA, 5 Yr. CAGR % | 28.47 | 34.13 | 24.04 | 35.47 | 26.9 | |||||
EBITA, 5 Yr. CAGR % | 19.62 | 7.09 | 7.15 | 23.76 | 11 | |||||
EBIT, 5 Yr. CAGR % | 17.27 | -33.79 | -10.13 | 20.36 | 7.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 49.78 | 0.62 | -19.48 | 1.36 | 0.06 | |||||
Net Income, 5 Yr. CAGR % | 48.35 | -2.02 | -19.48 | 1.36 | 0.06 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.03 | 13.36 | -24.45 | 15.67 | -7.76 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.83 | -27.65 | -38.34 | -15.69 | -6.24 | |||||
Accounts Receivable, 5 Yr. CAGR % | 105.59 | 101.6 | 78.09 | 73.6 | 49.09 | |||||
Inventory, 5 Yr. CAGR % | 68.64 | 99.61 | 96.56 | 95.4 | 9.07 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 94.64 | 92.87 | 117.59 | 106.93 | 56.61 | |||||
Total Assets, 5 Yr. CAGR % | 86.55 | 87.38 | 71.33 | 64.92 | 22.59 | |||||
Tangible Book Value, 5 Yr. CAGR % | 86.94 | 81 | 52.86 | 48.8 | 33.33 | |||||
Common Equity, 5 Yr. CAGR % | 81.69 | 81.76 | 64.8 | 60.62 | 23.52 | |||||
Cash From Operations, 5 Yr. CAGR % | 19.46 | 42.11 | 40.09 | 33.16 | 74.43 | |||||
Capital Expenditures, 5 Yr. CAGR % | 47.98 | 65.69 | 111.56 | 54.8 | 22.55 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 23.46 | 94.78 | 3.33 | 32.46 | 5.42 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 27.71 | 95.04 | 7.34 | 36.02 | 22.66 |
- Stock Market
- Equities
- SDV Stock
- Financials SciDev Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















